In the quest to combat cancer, innovation sits at the heart of every breakthrough. The relentless pursuit of effective therapies has led scientists on a path filled with challenges and triumphs. As many grapple with diseases like intrahepatic cholangiocarcinoma, breast and bladder cancers,
Ivan Kairatov, a highly respected expert in the Biopharma industry, delves into the groundbreaking findings surrounding PPP2R1A mutations in ovarian clear cell carcinoma (OCCC) and their implications for cancer treatment. With his deep understanding of biotechnology and innovation, Kairatov shares
Recent advancements in cancer research have unveiled a surprising potential therapeutic agent against one of the deadliest forms of cancer: pancreatic cancer. Central to this innovation is stevia, a plant usually celebrated for its role as a calorie-free sweetener. Now, through bacterial
In a groundbreaking move, Uniquity Bio has appointed industry veteran Will Kane as its new President and CEO amid its ambitious drive towards late-stage drug development. With over 30 years in the biopharmaceutical industry, Kane brings a wealth of experience from his previous executive roles at
In the realm of pharmaceutical research, decentralized clinical trials (DCTs) are emerging as a transformative force, promising to redefine how clinical studies are conducted. These trials address the traditional challenges that have long plagued clinical research, including limited participant
Picture the intricacies hidden within the cell—each nucleus containing a vast genome map, intricately folded into a complex three-dimensional (3D) shape. How does this hidden architecture influence the very essence of life, determining which genes are silent or expressed? The Importance of 3D DNA
